Jane brings knowledge and experience in multiple technologies to assist clients in patent portfolio management and strategy
Jane Kuzelka, PhD, focuses her practice on patent drafting and prosecution in the chemical sciences, with a particular emphasis on small molecule pharmaceuticals. She also has extensive experience with agricultural, cosmetic, peptide, and biofuel-based technologies. Jane works closely with her clients to develop and manage patent portfolio strategies, and assists with due diligence and freedom to operate analyses.
“Polyvalent Display of Heme on Hepatitis B Virus Capsid Protein through Coordination to Hexa(Histidine) Tags,” Chem. Biol. 15: 513-519 (2008) (coauthor).
“Synthesis and Characterization of Cu2(I,I), Cu2(I,II), and Cu2(II,II) Compounds Supported by Two Phthalazine-Based Ligands: Influence of a Hydrophobic Pocket,” Inorg. Chem. 43: 1751-1761 (2004) (coauthor).
“Modeling the Syn Disposition of Nitrogen Donors at the Active Sites of Carboxylate-Bridged Diiron Enzymes. Enforcing Dinuclearity and Kinetic Stability with a 1,2-Diethynylbenzene-Based Ligand,” Inorg. Chem. 42: 8652-8662 (2003) (coauthor).
“Modeling Features of the Non-Heme Diiron Cores in O2-Activating Enzymes through the Synthesis, Characterization, and Oxidation of 1,8-Naphthyridine-Based Complexes,” Inorg. Chem. 42: 6447-6457 (2003) (coauthor).
“Carboxylate-Bridged Diiron(II) Complexes with a Sterically Hindered Phthalazine Ligand,” Inorg. Chim. Acta 337: 212-222 (2002) (coauthor).